InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
60,000.00
(
-0.96%
)
Post# of 43344
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonDonDonDon

Send PM Follow Ignore
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

DonDonDonDon

Re: dloggold post# 29260

Thursday, 05/13/2021 5:07:56 PM

Thursday, May 13, 2021 5:07:56 PM

Post# of 43344

They are making 100000 treatments so 500 divided by 3 doses is 175 per vial or so,
They need 300,000 vials to treat 100000 patients


I was wondering if Durrant reconfirmed the 100,000 patient projection that he made March 29th. Because $51.4 million sounds like it would produce more than 100,000 treatments. IIRC, leronflimflam costs $40 to manufacture each dose. $40 divided into $51.4 million is 1.2 million doses. My guess is that lenzilumab costs more to produce but how much more?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up